SAN DIEGO, March 12, 2026 /PRNewswire/ — Aethlon Medical, Inc. (“Aethlon” or the “Company”) (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that it is evaluating a range of strategic…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
